• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How does the level of BCG vaccine protection against tuberculosis fall over time?

作者信息

Rodrigues Laura Cunha, Mangtani Punam, Abubakar Ibrahim

机构信息

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

BMJ. 2011 Sep 29;343:d5974. doi: 10.1136/bmj.d5974.

DOI:10.1136/bmj.d5974
PMID:21964347
Abstract
摘要

相似文献

1
How does the level of BCG vaccine protection against tuberculosis fall over time?卡介苗对结核病的保护水平如何随时间下降？
BMJ. 2011 Sep 29;343:d5974. doi: 10.1136/bmj.d5974.
2
[Tuberculosis vaccination and revaccination with BCG].[卡介苗接种与复种]
Feldsher Akush. 1988 Jan;53(1):17-22.
3
Vaccination against tuberculosis: how can we better BCG?结核疫苗接种：我们如何更好地使用卡介苗？
Microb Pathog. 2013 May;58:2-16. doi: 10.1016/j.micpath.2012.12.002. Epub 2012 Dec 17.
4
[Morphological study of tuberculin reaction to determine the body responsiveness in tuberculosis].[通过结核菌素反应的形态学研究来确定结核病患者机体反应性]
Probl Tuberk. 2003(3):45-8.
5
BCG Vaccine Protection Against Mycobacterium tuberculosis Infection by Level of Exposure in The Gambia.BCG 疫苗对冈比亚接触水平的结核分枝杆菌感染的保护作用。
J Infect Dis. 2021 Feb 24;223(4):719-720. doi: 10.1093/infdis/jiaa411.
6
Mouse and guinea pig models for testing new tuberculosis vaccines.用于测试新型结核病疫苗的小鼠和豚鼠模型。
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):13-7. doi: 10.1016/j.tube.2004.08.001. Epub 2005 Jan 22.
7
A Breath of Fresh Air: BCG Prevents Adult Pulmonary Tuberculosis.《BCG 预防成人肺结核：呼吸新鲜空气》
Int J Infect Dis. 2019 Mar;80S:S6-S8. doi: 10.1016/j.ijid.2019.02.036. Epub 2019 Feb 26.
8
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration.一种新型结核病疫苗：突破、挑战与合作呼吁。
Lancet Infect Dis. 2019 Feb;19(2):123-125. doi: 10.1016/S1473-3099(19)30003-9. Epub 2019 Jan 30.
9
Heterologous Boost Following Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.异源加强接种可减少迟发性而非早期鼻内结核感染挑战。
Front Immunol. 2018 Oct 30;9:2439. doi: 10.3389/fimmu.2018.02439. eCollection 2018.
10
BCG vaccine--current status.卡介苗——现状
J Indian Med Assoc. 2000 Mar;98(3):110-1, 114.

引用本文的文献

1
Spatial co-distribution of tuberculosis prevalence and low BCG vaccination coverage in Ethiopia.埃塞俄比亚结核病患病率与卡介苗低接种率的空间共同分布情况。
Sci Rep. 2024 Dec 30;14(1):31561. doi: 10.1038/s41598-024-68549-7.
2
Optimizing antigen selection for the development of tuberculosis vaccines.优化用于结核病疫苗研发的抗原选择。
Cell Insight. 2024 Mar 16;3(3):100163. doi: 10.1016/j.cellin.2024.100163. eCollection 2024 Jun.
3
Protection against tuberculosis achieved by dissolving microneedle patches loaded with live in a BCG prime-boost strategy.
采用负载活的微针贴片进行 BCG 初免-加强策略，实现对结核病的保护。
Front Immunol. 2023 Jun 16;14:1178688. doi: 10.3389/fimmu.2023.1178688. eCollection 2023.
4
A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy.纳米医学在抗结核治疗中的潜力现状展望
Trop Med Infect Dis. 2023 Feb 3;8(2):100. doi: 10.3390/tropicalmed8020100.
5
Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&D.影响疫苗研发时间表的障碍、关键障碍的识别、因果分析以及专家意见领袖对一般疫苗和新冠疫苗研发中关键障碍的优先级排序
Front Public Health. 2021 Apr 20;9:612541. doi: 10.3389/fpubh.2021.612541. eCollection 2021.
6
Timing of exposure explains variation in BCG effectiveness: a systematic review and meta-analysis.接种时机解释了卡介苗有效性的差异：系统评价和荟萃分析。
Thorax. 2021 Nov;76(11):1131-1141. doi: 10.1136/thoraxjnl-2020-216794. Epub 2021 Apr 23.
7
Induction of Trained Immunity by Recombinant Vaccines.重组疫苗诱导训练免疫。
Front Immunol. 2021 Jan 7;11:611946. doi: 10.3389/fimmu.2020.611946. eCollection 2020.
8
Tuberculosis vaccine development: from classic to clinical candidates.结核病疫苗研发：从经典到临床候选物。
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1405-1425. doi: 10.1007/s10096-020-03843-6. Epub 2020 Feb 15.
9
Prophylaxis of H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.通过雾化噬菌体D29吸入预防临床前小鼠模型中的H37Rv感染
Antimicrob Agents Chemother. 2019 Sep 9;63(12). doi: 10.1128/AAC.00871-19. Epub 2019 Sep 16.
10
Analysis of cellular and soluble profiles in QuantiFERON nonconverters, converters, and reverters in the Gambia.冈比亚中伽夫尼非转化者、转化者和再转化者的细胞和可溶性谱分析。
Immun Inflamm Dis. 2019 Dec;7(4):260-270. doi: 10.1002/iid3.269. Epub 2019 Aug 20.